Estimate the out-of-pocket cost for your treatment

Find treatment near you

Select from various services to view estimates for providers near you.

Personalize your estimate

Add your insurance information to receive an estimate tailored to your plan benefits.

Understand your costs

Estimate and compare costs across sites of care.

About this tool

This website was developed to help patients prescribed Kisunla understand costs associated with their treatment upfront. You can search for specific treatment steps, see which providers near you offer those treatments, and receive cost estimates. All prices in this tool reflect estimates, actual costs may differ if your benefits, insurance coverage, or treatment plan changes. You may also incur different costs if you receive additional care between looking up an estimate and starting your treatment. This tool provides cost estimates for the Kisunla infusions and brain MRI scans. Additional costs are possible as each individual patient has a unique care plan lead by the discretion of their prescribing healthcare provider.

This website is owned and operated by Turquoise Health.

What you can expect:

️Find providers that offer Kisunla treatment.

Receive an estimate by providing your insurance details.

Insurance not listed? We’ll show you an estimate based on average Medicare reimbursement.

Frequently Asked Questions

How can I make the most of the information provided?

Use this website to understand and compare prices for your Kisunla treatment. (See “What does the estimated price include?” for details.) We recommend confirming prices directly with your provider and/or insurance plan (if applicable).

Do my search results include all providers that offer Kisunla?

No. This website includes providers who have elected to participate at this time. Other providers may offer the same services but aren’t yet listed. We’re adding more providers over time — check back soon if you don’t see the provider you’re looking for.

Why isn't my insurance plan listed?

We prioritize the Medicare insurance plans by market share for patients prescribed Kisunla. We’re adding more insurance plans over time — check back soon if you don’t see yours.

You should not use this tool to compare prices if you are enrolled in a Commercial insurance or Medicaid plan.

Do the cost estimates include supplemental or secondary insurance coverage (such as Medigap or secondary plans) that I am enrolled in?

No. The cost estimates are based only on coverage from your primary insurance plan. It does not account for any supplemental or secondary insurance coverage, including Medigap. As a result, the actual amount you pay may be lower if you have additional coverage.

Do I need to provide any personal information for an estimate?

If you would like a personalized estimate that takes into account your real-time eligibility and benefits, you may opt to input your full name, date of birth, and member ID. We’ll apply your benefits to give you an estimate that more accurately represents your current out-of-pocket responsibilities. The tool does not collect or store any personally identifiable information (PII).

If you choose not to input any personal information, we’ll show you an estimate of the insurance rate for the service you’ve selected. It reflects the price a provider has negotiated with your insurance plan. Your out-of-pocket responsibility is often a portion of this rate, and will depend on your progress towards your deductible, out-of-pocket maximum and co-pay and/or co-insurance.

Which service should I select?

If you're starting Kisunla treatment for early symptomatic Alzheimer's disease, you can choose to view cost estimates. These include your pre-treatment baseline brain MRI scan, up to 6 months of infusions (starting with lower doses and building up to full 1400mg dose), and 3 monitoring brain MRI scans.

Alternatively, if you only need one part of the journey, you can select from the following options:

Infusion Only: Covers your Kisunla infusions for the first 6 doses including the step-up dosing period
Brain MRI Scan Only: Used for your baseline and ongoing monitoring throughout treatment

Consult with your provider to understand which selection is right for you.

What is a deductible?

A deductible is the amount you will pay out of pocket for covered healthcare services or prescription medications before your insurance plan starts to pay. Most insurance plans have a deductible requirement. The deductible phase is typically followed by the co-insurance phase where you will pay a percent of your covered healthcare services or prescription medication costs.

What is Co-pay / Co-Insurance Rate?

Co-pays are a fixed dollar value that patients are responsible for paying out-of-pocket. Alternatively, a co-insurance rate is a percentage of the covered price that the patient is responsible for paying out-of-pocket. Most insurance plans require patients to pay a percent of their covered prescription medication cost after their deductible has been met. Check your insurance plan details to verify your benefit design and out-of-pocket responsibilities.

What is an out-of-pocket maximum?

An out-of-pocket maximum is the most you will pay for covered healthcare services or prescription drugs in a calendar year before your insurance plan starts covering 100% of the costs. Most insurance plans have an out-of-pocket maximum. Deductible and co-insurance payments go towards your out-of-pocket maximum.

What extra steps might be required of my doctor to confirm my coverage?

Your Kisunla prescription may require a prior authorization. A prior authorization will be completed by your doctor. This document will likely include clinical information and details on your previous medications.

What is Turquoise Health?

Turquoise Health is a health care technology company committed to leveraging price transparency data to make health care prices easy to understand for everyone. To learn more, visit turquoise.health

Eli Lilly has partnered with Turquoise Health to help patients prescribed Kisunla understand their costs.

How does Turquoise Health determine price accuracy?

Turquoise Health obtains prices from multiple sources, including provider and insurance published data, as well as historical medical claims.

How often is the information in the tool updated?

Turquoise Health updates pricing data on a monthly basis. Estimates with insurance benefits applied are based on real-time benefits verification, so estimates may vary between uses of the tool.

Disclaimer

The company / plan names listed do not imply their endorsement of Lilly USA, LLC or the product referenced. Lilly USA, LLC does not endorse any particular plan. Other product and company names mentioned herein are the trademarks of their respective owners.

All prices shown are estimates. Individual treatment duration and responses may vary. Additional treatment-related costs may apply. The estimated number of infusions and brain MRI scans for the 6-month treatment plan may vary. The dosing and brain MRI scan schedule represented is based on the recommendations in the Kisunla Prescribing Information. To be eligible for treatment, patients must have a confirmed diagnosis of early symptomatic Alzheimer's disease and amyloid plaque in the brain. Please consult with your healthcare provider.

This list may not be an exhaustive list of all plans in your area and the coverage of other plans in your area may vary.

This information is not a guarantee of coverage or payment (partial or full). All coverage determinations are subject to the insured's plan, prescription, and insurer approval. Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. Please contact your insurance provider directly to confirm the accuracy of all coverage details obtained through this tool. We assume no responsibility or liability for payment of any claims, costs, or coverage decisions.

The definitions provided in the FAQ section are for general informational purposes only and may not reflect the specific terms of your insurance coverage. Patients are encouraged to consult their individual insurance plan documents or contact their insurance plan directly for further information.

Safety Summary with Warnings

Warnings - Kisunla can cause Amyloid-Related Imaging Abnormalities or “ARIA.” This is a common side effect that does not usually cause any symptoms, but serious symptoms can occur. ARIA can be fatal. ARIA is most commonly seen as temporary swelling in an area or areas of the brain that usually goes away over time. Some people may also have spots of bleeding on the surface of or in the brain and infrequently, larger areas of bleeding in the brain can occur. Although most people do not have symptoms, some people have:

Headache
Dizziness
Nausea
Difficulty walking

Confusion
Vision changes
Seizures

Some people have a genetic risk factor (homozygous apolipoprotein E ε4 gene carriers) that may cause an increased risk for ARIA. Talk to your healthcare provider about testing to see if you have this risk factor.

You may be at higher risk of developing bleeding in the brain if you take medicines to reduce blood clots from forming (antithrombotic medicines) while receiving Kisunla. Talk to your healthcare provider to see if you are on any medicines that increase this risk.

Your healthcare provider will do magnetic resonance imaging (MRI) brain scans before and during your treatment with Kisunla to check you for ARIA. You should carry information that you are receiving Kisunla, which can cause ARIA, and that ARIA symptoms can look like stroke symptoms. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the symptoms listed above.

There are registries that collect information on treatments for Alzheimer’s disease. Your healthcare provider can help you become enrolled in these registries.

Warnings - Kisunla can cause serious allergic and infusion-related reactions. Do not receive Kisunla if you have serious allergic reactions to donanemab-azbt or any of the ingredients in Kisunla. Symptoms may include swelling of the face, lips, mouth, or eyelids, problems breathing, hives, chills, irritation of skin, nausea, vomiting, sweating, headache, or chest pain. You will be monitored for at least 30 minutes after you receive Kisunla for any reaction. Tell your healthcare provider right away if you have these symptoms or any reaction during or after a Kisunla infusion.

Other common side effects

Headache

Tell your healthcare provider right away if you have any side effects. These are not all of the possible side effects of Kisunla. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before you receive Kisunla, tell your healthcare provider:

About all medicines you take, including prescription and over-the-counter medicines, as well as vitamins and herbal supplements. Especially tell your healthcare provider if you have medicines to reduce blood clots from forming (antithrombotic medicines, including aspirin).
About all of your medical conditions including if you are pregnant, breastfeeding, or plan to become pregnant or breastfeed. Kisunla has not been studied in people who were pregnant or breastfeeding. It is not known if Kisunla could harm your unborn or breastfeeding baby.

How to receive Kisunla

Kisunla is a prescription medicine given through an intravenous (IV) infusion using a needle inserted into a vein in your arm. Kisunla is given once every 4 weeks. Each infusion will last about 30 minutes.

Learn more

For more information about Kisunla, call 1-800-LillyRx (1-800-545-5979) or go to kisunla.lilly.com.

This summary provides basic information about Kisunla. It does not include all information known about this medicine. Read the information given to you about Kisunla. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Kisunla. Your healthcare provider is the best person to help you decide if Kisunla is right for you.

DN CON BS APP

Kisunla® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Indication

Kisunla® (kih-SUHN-lah) is used to treat adults with early symptomatic Alzheimer’s disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.